原著・論文2016年

Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
Sugimoto K, Moriyasu F, Saito K, Kobayashi Y, Itoi T.
J Med Ultrason (2001). 2016 Dec 8. [Epub ahead of print]

World J Radiol. 2016 Nov 28;8(11):857-867.
Diffusion-weighted imaging of the liver: Current applications.
Saito K, Tajima Y, Harada TL.
World J Radiol. 2016 Nov 28;8(11):857-867.

Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer.
Kennoki N, Nakayama H, Nagakawa Y, Hosokawa Y, Itonaga T, Tajima YU, Shiraishi S, Mikami R, Tsuchida A, Tokuuye K.
Mol Clin Oncol. 2016 Jan;4(1):43-46. Epub 2015 Oct 29.

Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study.
Shirota N, Saito K, Sugimoto K, Takara K, Moriyasu F, Tokuuye K.
Cancer Imaging. 2016 Jan 29;16(1):1. doi: 10.1186/s40644-016-0059-3.

Distinguishing liver haemangiomas from metastatic tumours using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced diffusion-weighted imaging at 1.5T MRI.
Saito K, Yoshimura N, Shirota N, Saguchi T, Sugimoto K, Tokuuye K.
J Med Imaging Radiat Oncol.2016 Oct;60(5):599-606. doi: 10.1111/1754-9485.12487.

Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y, Nakashima J, Yunaiyama D, Sugihara T, Gondo T, Nakagami Y, Horiguchi Y, Ohno Y, Namiki K, Ohori M, Tokuuye K, Tachibana M.
Ann Surg Oncol. 2016 Oct 3.

コメントは受け付けていません。